top of page
14 févr. 2024
Temisis completed the first phase of a new capital increase, led by SFHBB, to fund clinical development of its promising psoriasis drug candidate.
Groupe PAT – New capital increase at Temisis with Société Financière Hoche Bains les Bains
Société Financière Hoche Bains les Bains (SFHBB), specialized in equity investment, and Plant Advanced Technologies PAT, a pioneering company in the discovery and production of rare plant biomolecules, announce the closing of the first phase of a second fundraising , for Temisis, a subsidiary of PAT, valued at 45 million euros premoney.
Download Plant Advanced Technologies press release (in french)
bottom of page